Anzeige
Mehr »
Login
Freitag, 05.06.2020 Börsentäglich über 12.000 News von 628 internationalen Medien
Der goldene Meilenstein mit frappanten Auswirkungen für die Zukunft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DJR2 ISIN: SE0009268717 Ticker-Symbol: 7AC 
Frankfurt
05.06.20
15:31 Uhr
0,115 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ACARIX AB Chart 1 Jahr
5-Tage-Chart
ACARIX AB 5-Tage-Chart

Aktuelle News zur ACARIX Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ACARIX Aktie jetzt für 0€ handeln
14.05.Acarix AB: Announcement from Acarix's annual general meeting4
14.05.Acarix AB (publ) publishes Interim Report, January - March 2020-
11.05.Acarix AB: Last patient included in Acarix's exploratory heart failure study SEISMO145Press releaseMalmö, Sweden May 11, 2020 Last patient included in Acarix's exploratory heart failure study SEISMO Acarix AB (publ) today announced that the last patient has been included in the...
► Artikel lesen
23.04.Acarix AB: Acarix publishes the annual report for 2019135Press release Malmö, April 23, 2020 Acarix publishes the annual report for 2019 Today, Thursday April 23, Acarix is publishing its Annual Report for 2019 on the company website www.acarix.com. The...
► Artikel lesen
14.04.Notice of Annual General Meeting in Acarix AB206Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the annual general meeting to be held on Thursday 14 May...
► Artikel lesen
14.04.Notice of Annual General Meeting in Acarix AB-
12.03.BRIEF-Acarix Receives Feedback On German Reimbursement Submission2
12.03.Acarix AB: Acarix receives feedback on German reimbursement submission205Press releaseMalmö, Sweden March 12, 2020 Acarix receives feedback on German reimbursement submission Acarix AB (publ) today announced that the company has received feedback from the German...
► Artikel lesen
20.02.BRIEF-Acarix Q4 Revenue Up At SEK 774,0002
20.02.Acarix AB: Successful rights issue enables increased focus on strategic initiatives165Acarix AB (publ) publishes Year-End Report 2019 Malmö, January 20, 2020 Successful rights issue enables increased focus on strategic initiatives The fourth quarter of 2019 was eventful,...
► Artikel lesen
18.02.Acarix AB: First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients178Press release Malmö, Sweden February 18, 2020 First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients Acarix AB (publ) today announced the initiation of the...
► Artikel lesen
14.01.Acarix AB: First patients with the CADScorSystem in the UK237Press release Malmö, Sweden January 14, 2020 First patients with the CADScorSystem in the UK Acarix AB (publ) (ACARIX: FN Stockholm) today announced the first commercial usage of the CADScorSystem in...
► Artikel lesen
03.01.Acarix - The de novo beat422Acarix has announced that the FDA is reviewing a de novo 510(k) application for its innovative CADScor cardiac diagnostic device. This is important news as it could mean that Acarix might enter the...
► Artikel lesen
20.12.19ACARIX AB: Redeye initiates coverage of Acarix2
16.12.19Acarix AB: Acarix submits FDA application230Press release Malmö, Sweden 16 December, 2019 Acarix submits FDA application Acarix AB (publ) (ACARIX: FN Stockholm) today announced the submission of a De Novo application to the American...
► Artikel lesen
27.11.19Nasdaq Stockholm AB: Last day of trading in paid subscription shares (BTA) of Acarix AB (publ) (418/19)204Trading in Acarix AB (publ) paid subscription shares is to cease. The last trading day is December 2, 2019. Short name: ACARIX BTA 1 --------------------------- ISIN code: SE0013235892 --------------------------- Orderbook...
► Artikel lesen
06.11.19Acarix - Rights funding completed255Acarix has competed a rights issue of 28.67m shares at SEK1.50/share to raise SEK43m before expenses. The proceeds will fund a programme of market development and clinical trials. The process for German...
► Artikel lesen
09.10.19Nasdaq Stockholm AB: Trading in subscription rights and paid subscription shares in Acarix AB (publ) (346/19)404As from October 10, 2019, subscription rights (TR) issued by Acarix AB (publ) will be traded on First North Premier Growth Market. Trading will continue until October 23, 2019. Instrument: ...
► Artikel lesen
02.10.19XFRA CAPITAL ADJUSTMENT INFORMATION - 03.10.2019 - 1556FOLGENDE WERTPAPIERE WERDEN AM 02.10.2019 CUM KAPITALMASSNAHME UND AM 03.10.2019 EX KAPITALMASSNAHME GEHANDELT. THE FOLLOWING SHARES ARE TRADED CUM CAPITAL ADJUSTMENT ON 02.10.2019 AND EX CAPITAL ADJUSTMENT...
► Artikel lesen
27.08.19Acarix - Patch reordering and an emerging US strategy181CADScor H1 unit sales were to Germany (six), Sweden (three) and Denmark (one). Interestingly, Q219 patch sales were very strong at 1,690 up from 640 in Q119. These 1000 'extra' sales could be an indication...
► Artikel lesen
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1